Exit association-mediated suicide: Toxicologic and forensic aspects

American Journal of Forensic Medicine and Pathology

Volumn 20, Issue 1, 1999, Pages 40-44

  Giroud, Christian ^a   Augsburger, M ^a   Horisberger, B ^a   Lucchini, P ^b   Rivier, L ^a   Mangin, P ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b Inst Cantonale di Patol di Locarno   (Switzerland)

Author keywords

Barbiturates; Euthanasia; Pentobarbital; Suicide

Indexed keywords

BARBITURIC ACID DERIVATIVE; PENTOBARBITAL;

ARTICLE; EUTHANASIA; LEGAL ASPECT; SUICIDE; SWITZERLAND;

EID: 0032955947     PISSN: 01957910     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000433-199903000-00010     Document Type: Article

References (9)

1. Muri P. "Exit" ou comment mourir dignement ["Exit", or how to die in dignity]. L'illustré 1995;13:10-13.
2. Humphry D. Exit final, pour une mort dans la dignite [Final Exit, a death with dignity]. Paris: Le Jour, 1991.
3. Guillon C, Le Bonniec Y. Suicide, mode d'emploi, histoire, technique, actualité [Suicide, a user's manual, history, techniques, news]. Paris: Alain Moreau, 1982.
4. Baselt RC, Cravey RH. Disposition of toxic drugs and chemicals in man, 4th ed. Foster City, CA: Chemical Toxicology Institute, 1995:595-8.
5. Moffat AC, ed. Clarke's isolation and identification of drugs in pharmaceuticals, body fluids, and postmortem material, 2nd ed. London: The Pharmaceutical Press, 1986: 863-4.
6. Martindale, the extra pharmacopoeia: evaluated information on the world's drugs and medicines, 31st ed. London: The Royal Pharmaceutical Society, 1996:727.
7. Smith RB, Dittert LW, Griffen WO Jr, Doluisio JT. Pharmacokinetics of pentobarbital after intravenous and oral administration. J Pharmacokinet Biopharm 1973;1:5-16.
8. Ehrnebo M. Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration. J Pharm Sci 1974;63:1114-8.
9. Wagner JG. Pharmacokinetics for the pharmaceutical scientist. Basel, Switzerland: Technomic publishing AG, 1993: 22-3.